A detailed history of Panagora Asset Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 2,554 shares of CRL stock, worth $469,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,554
Previous 4,360 41.42%
Holding current value
$469,936
Previous $1.18 Million 55.38%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$206.39 - $268.73 $372,740 - $485,326
-1,806 Reduced 41.42%
2,554 $527,000
Q1 2023

May 11, 2023

SELL
$191.89 - $259.92 $485,865 - $658,117
-2,532 Reduced 36.74%
4,360 $879,000
Q4 2022

Feb 13, 2023

BUY
$197.11 - $250.07 $821,948 - $1.04 Million
4,170 Added 153.2%
6,892 $1.5 Million
Q1 2022

May 12, 2022

BUY
$255.51 - $362.11 $488,790 - $692,716
1,913 Added 236.46%
2,722 $773,000
Q4 2021

Feb 10, 2022

SELL
$351.38 - $448.68 $405,141 - $517,328
-1,153 Reduced 58.77%
809 $305,000
Q3 2021

Nov 10, 2021

SELL
$372.64 - $458.3 $41,363 - $50,871
-111 Reduced 5.35%
1,962 $810,000
Q2 2021

Aug 11, 2021

SELL
$294.17 - $371.65 $11,472 - $14,494
-39 Reduced 1.85%
2,073 $767,000
Q1 2021

May 12, 2021

SELL
$249.67 - $299.48 $6,741 - $8,085
-27 Reduced 1.26%
2,112 $612,000
Q4 2020

Feb 10, 2021

BUY
$222.0 - $252.62 $14,652 - $16,672
66 Added 3.18%
2,139 $534,000
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $175 - $226
-1 Reduced 0.05%
2,073 $469,000
Q2 2020

Aug 12, 2020

SELL
$118.84 - $189.72 $118 - $189
-1 Reduced 0.05%
2,074 $362,000
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $13,351 - $24,075
-135 Reduced 6.11%
2,075 $262,000
Q4 2019

Feb 12, 2020

BUY
$126.05 - $152.76 $17,016 - $20,622
135 Added 6.51%
2,210 $338,000
Q3 2019

Nov 12, 2019

SELL
$125.07 - $143.67 $5.12 Million - $5.88 Million
-40,910 Reduced 95.17%
2,075 $275,000
Q2 2019

Aug 09, 2019

SELL
$123.4 - $148.55 $7.91 Million - $9.53 Million
-64,130 Reduced 59.87%
42,985 $6.1 Million
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $327,248 - $458,091
-3,122 Reduced 2.83%
107,115 $15.6 Million
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $8.82 Million - $11.5 Million
-83,963 Reduced 43.24%
110,237 $12.5 Million
Q3 2018

Nov 13, 2018

SELL
$112.11 - $134.54 $1.02 Million - $1.22 Million
-9,079 Reduced 4.47%
194,200 $26.1 Million
Q2 2018

Aug 14, 2018

SELL
$102.37 - $117.25 $550,852 - $630,922
-5,381 Reduced 2.58%
203,279 $22.8 Million
Q1 2018

May 15, 2018

SELL
$98.19 - $115.2 $12.3 Million - $14.4 Million
-124,908 Reduced 37.45%
208,660 $22.3 Million
Q4 2017

Feb 14, 2018

SELL
$100.43 - $118.09 $12 Million - $14.2 Million
-119,923 Reduced 26.44%
333,568 $36.5 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $43.9 Million - $49.5 Million
453,491
453,491 $49 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.36B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.